ArticleEuropean journal of nuclear medicine and molecular imaging2013

Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response.

Wael A AlJaroudi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.